| __timestamp | Alkermes plc | Arrowhead Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 170914000 | 175000 |
| Thursday, January 1, 2015 | 144942000 | 382000 |
| Friday, January 1, 2016 | 226424000 | 158333 |
| Sunday, January 1, 2017 | 335737000 | 31407709 |
| Monday, January 1, 2018 | 492448000 | 16142321 |
| Tuesday, January 1, 2019 | 477729000 | 168795577 |
| Wednesday, January 1, 2020 | 465852000 | 87992066 |
| Friday, January 1, 2021 | 569838000 | 138287000 |
| Saturday, January 1, 2022 | 893687000 | 232810000 |
| Sunday, January 1, 2023 | 1410368000 | 240735000 |
| Monday, January 1, 2024 | 1312301000 | 3551000 |
In pursuit of knowledge
In the dynamic world of biopharmaceuticals, understanding financial health is crucial. Over the past decade, Alkermes plc has consistently outperformed Arrowhead Pharmaceuticals, Inc. in terms of gross profit. From 2014 to 2023, Alkermes saw a staggering 726% increase in gross profit, peaking at approximately $1.41 billion in 2023. In contrast, Arrowhead's growth, while notable, was more modest, with a peak gross profit of around $240 million in 2023.
Alkermes' robust growth trajectory highlights its strategic prowess in the industry, while Arrowhead's steady climb reflects its potential and resilience. However, the data for 2024 is incomplete, leaving room for speculation on future trends. As these companies continue to innovate, investors and stakeholders should keep a keen eye on their financial performances to gauge their market positions.
Key Insights on Gross Profit: Merck & Co., Inc. vs Alkermes plc
Gross Profit Analysis: Comparing Amgen Inc. and Alkermes plc
Who Generates Higher Gross Profit? Gilead Sciences, Inc. or Alkermes plc
GSK plc and Alkermes plc: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: BioMarin Pharmaceutical Inc. vs Alkermes plc
Lantheus Holdings, Inc. and Arrowhead Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Alkermes plc vs MorphoSys AG
Who Generates Higher Gross Profit? Alkermes plc or BioCryst Pharmaceuticals, Inc.
Gross Profit Comparison: Arrowhead Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated Trends
Arrowhead Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis